COVID-19: all 7,775 studies

Page 26 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• Reducing Parental Stress Via Instant Messaging During COVID-19 Pandemic: A Randomized Controlled TrialCompletedNCT05413577Not applicable
• Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)WithdrawnNCT05411575Phase 2
• COVID-19 Genomic Sequencing for Nosocomial Outbreak InvestigationsCompletedNCT05411562
• Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron StrainCompletedNCT05411471Phase 2
• Effects of Telerehabilitative Aerobic and Relaxation Exercises Patients With Type 2 Diabetes With and Without COVID-19CompletedNCT05411458Not applicable
• Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 PandemicCompletedNCT05410808
• Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in GuineaActive, not recruitingNCT05409300Phase 2
• Understanding COVID-19 Infections in Pregnant Women and Their Babies in 5 African Nations (periCOVID Africa)CompletedNCT05409274
• Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 VaccineActive, not recruitingNCT05409261Phase 2
• The Change of Clinical Features and Surgical Outcomes in Patients With Pressure Injury During the COVID-19 Pandemic: A Retrospective StudyCompletedNCT05409170
• Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients.Status unknownNCT05408481
• Intercellular Adhesion Molecule-1 and TNF-α in Patients With COVID-19CompletedNCT05408325
• Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and AboveCompletedNCT05408312Phase 1
• Comparative Study of Patterns of Immune Response to COVID 19 VaccinationStatus unknownNCT05408299
• Inhibition of Bradykinin in COVID-19 Infection With IcatibantCompletedNCT05407597Phase 2/3
• Intradermal Tozinameran for Patients With Immune-mediated Dermatologic DiseasesCompletedNCT05406908Phase 4
• Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome.CompletedNCT05405335Not applicable
• Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)CompletedNCT05405296
• Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in AdultsActive, not recruitingNCT05405283Phase 3
• Comparison of the Results of Bronchoalveolar Lavage Culture and Endotracheal Aspirate Culture in Intubated Critically Ill COVID-19 PatientsCompletedNCT05403489
• The Effect of Covid-19 on the Disease Course of Multiple Sclerosis :Belgian Lessons Learned From Rocky I to Rocky IVCompletedNCT05403463
• StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands.CompletedNCT05403359
• Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)TerminatedNCT05403346
• A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in BrazilCompletedNCT05403307
• α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19CompletedNCT05401773
• Effect of Mask Use on Hemodynamic Responses During ExertionCompletedNCT05401331Not applicable
• Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19)CompletedNCT05398965Phase 2
• Impact of COVID-19 Vaccination on Serum 25-hydroxyvitamin D LevelCompletedNCT05398939
• Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the ElderlyCompletedNCT05398926Phase 4
• Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)CompletedNCT05398848Phase 3
• Promoting HIV Self-testing Among MSM During COVID-19 PandemicStatus unknownNCT05398835Not applicable
• Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19Status unknownNCT05398731
• Study on Sotrovimab and Its Impact on the Immune Response to COVID-19 Infection in Real-life in the UAE and BahrainStatus unknownNCT05398718
• Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19CompletedNCT05398705Phase 2
• Long COVID-19 Rehabilitation & Recovery Research ProgramTerminatedNCT05398692Not applicable
• A Study of Modified mRNA Vaccines in Healthy AdultsCompletedNCT05397223Phase 1
• A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19Status unknownNCT05396573Phase 1
• COPD Circuit ExerciseCompletedNCT05395390Not applicable
• Psychological Well-being and Burnout in Healthcare Workers During the COVID-19 (Coronavirus Disease 2019) PandemicCompletedNCT05394051Not applicable
• A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19Status unknownNCT05394012Phase 1
• SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk PopulationsWithdrawnNCT05393999Phase 2
• COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster DoseCompletedNCT05392075
• Pathophysiology of Gas Exchange and Time Course Changes in Spontaneously Breathing Patients With Acute Respiratory Failure Due to COVID-19. A Multicenter Prospective Study.CompletedNCT05392062Not applicable
• Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae With tDCSCompletedNCT05389592Not applicable
• A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy AdultsActive, not recruitingNCT05389319Phase 1
• COVID-19 on Disease Activity in Radiologically Isolated Syndrome CohortCompletedNCT05387395
• Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)WithdrawnNCT05387317Phase 3
• Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)SuspendedNCT05387278Phase 1
• Glucoside- and Rutinoside-rich Crude Material for Relieving Side Effects of COVID-19 VaccinesStatus unknownNCT05387252Not applicable
• Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19SuspendedNCT05387239Phase 2
• Long-term Impact on Cardiopulmonary Function and Quality of Life in Patients Recovered From COVID-19.Status unknownNCT05386485
• A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19TerminatedNCT05386472Phase 1
• Study of the Use of the Drug Ingaron in Patients With COVID-19CompletedNCT05386459
• Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19CompletedNCT05386446
• Paxlovid in the Treatment of COVID-19 Patients With UremiaStatus unknownNCT05386433Early Phase 1
• A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.Status unknownNCT05386420Not applicable
• Telemedically Assisted Sampling of COVID-19 Patients - Is the Sampling Quality SufficientActive, not recruitingNCT05386407Not applicable
• Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.CompletedNCT05385991Phase 1
• Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19CompletedNCT05385029
• Crowdsourcing an Open COVID-19 Imaging Repository for AI ResearchCompletedNCT05384912
• Kidney Precision Medicine Project (KPMP) - COVID-19 ProtocolCompletedNCT05384899
• Impact of New Variants and Vaccines on the Course of COVID-19CompletedNCT05384886
• Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 PatientsStatus unknownNCT05384574Not applicable
• Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in AdultsCompletedNCT05383560Phase 2
• Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and AboveActive, not recruitingNCT05382871Phase 3
• Breather Trainer Versus Pulmonary Rehabilitation on Cardiopulmonary EfficiencyStatus unknownNCT05382780Not applicable
• INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and KenyaCompletedNCT05382130Not applicable
• Pulmonary and Extrapulmonary Impairments in Patients With Post COVID-19CompletedNCT05381727
• Long-Term Respiratory Muscle Strength in Young COVID-19 PatientsCompletedNCT05381714
• Short Term Results of Tele-RehabilitationCompletedNCT05381675Not applicable
• A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19Status unknownNCT05381519Phase 2
• Impact of COVID 19 on Psoriasis PatientsStatus unknownNCT05381402
• Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected ChildrenTerminatedNCT05381363Phase 1/2
• Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and AboveCompletedNCT05381350Phase 3
• Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19CompletedNCT05379621
• Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.CompletedNCT05379608Not applicable
• Echocardiographic Manifestation in Patients With Omicron Variant of COVID-19Status unknownNCT05379543
• Pulmonary Rehabilitation Program With Pulsed Electromagnetic Field Therapy in Patients With Post-covid Sequelae.Status unknownNCT05379517Not applicable
• Immune Responses to COVID-19 Infection or VaccinationCompletedNCT05379478
• The Impact of the COVID-19 Pandemic on the Career Choice of MedicineCompletedNCT05379465
• Outcomes of Neonates Born to Mothers With SARS-CoV-2 Infection in ShanghaiTerminatedNCT05379452
• Older Adults' Perceptions of the Impact COVID-19 PandemicCompletedNCT05379426
• Clinical and Electronic Record for Patients With COVID-19 Treated With the Assisted Breathing Helmet - ELMO in CearáStatus unknownNCT05375799
• Epidemiological Study on Asymptomatic Infections and Mild Illness With Covid-19 in ShanghaiStatus unknownNCT05375786
• Povidone Iodine Nasal Irrigation and Gargling to Reduce Viral Load in Asymptomatic Patients With COVID-19Status unknownNCT05375773Not applicable
• Complicated Appendicitis During the COVID-19 Pandemic in JordanCompletedNCT05375058
• Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and AboveActive, not recruitingNCT05374954Phase 3
• A Retrospective Study in Patients With Mild to Moderate COVID-19Status unknownNCT05374772
• The Effects of Video-based Yoga Interventions for Patients With Post-corona Virus DiseaseCompletedNCT05374668Not applicable
• Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After Coronavirus Disease (COVID-19)Active, not recruitingNCT05374577
• Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and OlderCompletedNCT05373485Phase 1
• Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and OlderCompletedNCT05373472Phase 2
• Effect of a Third COVID-19 Booster Among Health Care WorkersCompletedNCT05373459
• Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical StudyStatus unknownNCT05373446Phase 2
• To Evaluate SSD8432/Ritonavir in Adults With COVID-19Status unknownNCT05373433Phase 2/3
• COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic DisparitiesCompletedNCT05373420
• Low Versus Moderate-intensity Aerobic Training in Post-discharge COVID-19 SubjectsCompletedNCT05373407Not applicable
• Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 VaccineStatus unknownNCT05373030Phase 4
• Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and AdolescentsWithdrawnNCT05372783Phase 2
• Phase 3 Boosting Study for the SARS-CoV-2 rS Variant VaccinesCompletedNCT05372588Phase 3

← COVID-19 overview